These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9576191)

  • 1. Mobilization of Philadelphia-negative peripheral blood progenitor cells with chemotherapy and rhuG-CSF in chronic myelogenous leukaemia patients with a poor response to interferon-alpha.
    Carella AM; Simonsson B; Link H; Lennard A; Boogaerts M; Gorin NC; Tomas-Martinez JF; Dabouz-Harrouche F; Gautier L; Badri N
    Br J Haematol; 1998 Apr; 101(1):111-8. PubMed ID: 9576191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase.
    Olsson-Strömberg U; Höglund M; Björkholm M; Braide I; Carlson K; Gahrton G; Grimfors G; Hast R; Lerner R; Linder O; Ljungman P; Löfvenberg E; Malm C; Nilsson PG; Paul C; Rödjer S; Stenke L; Tidefeldt U; Turesson I; Uden AM; Wahlin A; Vilen L; Winqvist I; Zettervall O; Oberg G; Simonsson B
    Leuk Lymphoma; 2006 Sep; 47(9):1768-73. PubMed ID: 17064986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collection of Ph-negative progenitor cells with granulocyte-colony stimulating factor in patients with chronic myeloid leukaemia who respond to recombinant alpha-interferon.
    Reiffers J; Taylor K; Gluckman E; Gorin NC; Mahon FX; Micléa JM; Destrée D; Gautier L
    Br J Haematol; 1998 Aug; 102(3):639-46. PubMed ID: 9722288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idarubicin, intermediate-dose cytarabine, etoposide, and granulocyte-colony-stimulating factor are able to recruit CD34+/HLA-DR- cells during early hematopoietic recovery in accelerated and chronic phases of chronic myeloid leukemia.
    Carella AM; Frassoni F; Podestá M; Pungolino E; Pollicardo N; Ferrero R; Soracco M
    J Hematother; 1994; 3(3):199-202. PubMed ID: 7530135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful autografting in chronic myelogenous leukaemia using Philadelphia negative blood progenitor cells mobilized with rHuG-CSF alone in a patient responding to alpha-interferon.
    Carreras E; Sierra J; Rovira M; Urbano-Ispizua A; Martinez C; Nomdedeu B; Cervantes F; Marín P; Rozman C; Montserrat E
    Br J Haematol; 1997 Feb; 96(2):421-3. PubMed ID: 9029037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
    Hernández-Boluda JC; Carreras E; Cervantes F; Marín P; Arellano-Rodrigo E; Rovira M; Solé F; Lloveras E; Espinet B; Ocejo A; Montserrat E
    Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3.
    Aulitzky WE; Neubauer A; Kolbe K; Schneller F; Busemann C; Schleiermacher E; Peschel C; Siegert W; Huber C; Huhn D
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S67-9. PubMed ID: 8769707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia with different clinical stages.
    Gopcsa L; Barta A; Banyai A; Foldi J; Kalasz L; Pajor L; Gidali J; Regeczy N; Paloczi K
    Acta Haematol; 2001; 106(3):100-5. PubMed ID: 11713374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens.
    Deininger M; Pönisch W; Krahl R; Leiblein S; Edel E; Lange T; Fiedler F; Freund M; Franke A; Pasold R; von Grünhagen U; Herold M; Dölken G; Hoffmann FA; Uhle R; Schultze W; Steglich J; Schwarzer A; Richter P; Winkelmann C; Kettner E; Dachselt K; Subert R; Schwalbe E; Doepper J; Helbig W; Niederwieser D;
    Bone Marrow Transplant; 2001 Jun; 27(11):1125-32. PubMed ID: 11551022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CML.
    Heinzinger M; Waller CF; Rosenstiel A; Scheid S; Burger KJ; Lange W
    Leukemia; 1998 Mar; 12(3):333-9. PubMed ID: 9529127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony-stimulating factor-supported high-dose cytarabine and mitoxantrone.
    Schlenk RF; Döhner H; Pförsich M; Benner A; Fischer K; Hartmann F; Fischer JT; Weber W; Gunzer U; Pralle H; Haas R
    Br J Haematol; 1997 Nov; 99(2):386-93. PubMed ID: 9375760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon.
    McBride NC; Cavenagh JD; Newland AC; Lillington DM; Murrell C; Kelsey SM
    Bone Marrow Transplant; 2000 Dec; 26(11):1165-72. PubMed ID: 11149726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia.
    Carella AM; Cunningham I; Lerma E; Dejana A; Benvenuto F; Podestà M; Celesti L; Chimirri F; Abote M; Vassallo F; Figari O; Parodi C; Sessarego M; Valbonesi M; Carlier P; Prencipe E; Gatti AM; van den Berg D; Hoffman R; Frassoni F
    J Clin Oncol; 1997 Apr; 15(4):1575-82. PubMed ID: 9193355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-alpha.
    Michallet M; Thiébaut A; Philip I; Charrin C; Vigouroux C; Thomas X; Bilger K; Belhabri A; Guyotat D; Corront B; Salles B; Dumontet C; Péaud PY; Vilque JP; Devidas A; Fière D
    Leukemia; 2000 Dec; 14(12):2064-9. PubMed ID: 11187894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer.
    Filip S; Bláha M; Odrázka K; Mericka P; Vávrová J
    J Hematother Stem Cell Res; 2000 Feb; 9(1):31-8. PubMed ID: 10738969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia.
    Carella AM; Podesta M; Frassoni F; Raffo MR; Pollicardo N; Pungolino E; Vimercati R; Sessarego M; Parodi C; Rabitti C
    Bone Marrow Transplant; 1993 Sep; 12(3):267-71. PubMed ID: 7694724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization.
    Gajewski JL; Rondon G; Donato ML; Anderlini P; Korbling M; Ippoliti C; Benyunes M; Miller LL; LaTemple D; Jones D; Ashby M; Hellmann S; Durett A; Lauppe J; Geisler D; Khouri IF; Giralt SA; Andersson B; Ueno NT; Champlin R
    Biol Blood Marrow Transplant; 2002; 8(10):550-6. PubMed ID: 12434950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-finding study of lenograstim (glycosylated rHuG-CSF) for peripheral blood stem cell mobilization during postoperative adjuvant chemotherapy in patients with breast cancer. Lenograstim/Breast Cancer Study Group.
    Narabayashi M; Takeyama K; Fukutomi T; Tokuda Y; Tajima T; Okumura A; Chou T; Sano M; Makino H; Igarashi T; Sasaki Y; Imoto S; Ogura M; Morishima Y; Murai H; Okamoto S; Ikeda T; Kasai M; Yokozawa T; Tobinai K
    Jpn J Clin Oncol; 1999 Jun; 29(6):285-90. PubMed ID: 10418556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.